Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 1/20 | 0.36 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PRNP | P04156 | 1/20 | 0.31 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.30 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19978065 | 0.89 | TNKS (0.33) | TNKSTNKS2MAPTMEN1RAB9A | |
| SCHEMBL15416938 | 0.82 | TNKS (0.36) | TNKSTNKS2MAPTMEN1RAB9A | |
| SCHEMBL15416774 | 0.82 | TNKS (0.36) | TNKSTNKS2MAPTMEN1RAB9A | |
| SCHEMBL19978067 | 0.78 | TNKS (0.39) | TNKSTNKS2MAPTMEN1RAB9A | |
| SCHEMBL19978059 | 0.73 | ALDH1A1 (0.40) | MAPTMEN1KMT2AGPR3ALDH1A1 | |
| SCHEMBL19978063 | 0.70 | GPR3 (0.40) | TNKSTNKS2MAPTMEN1RAB9A | |
| SCHEMBL15126766 | 0.69 | TDP1 (0.36) | TNKSTNKS2MAPTMEN1RAB9A | |
| SCHEMBL19978068 | 0.69 | TDP1 (0.38) | MEN1RAB9AKMT2AALDH1A1CYP1A2 | |
| SCHEMBL21718193 | 0.68 | GPR3 (0.42) | TNKSTNKS2MAPTMEN1RAB9A | |
| SCHEMBL14951373 | 0.68 | TDP1 (0.35) | TNKSTNKS2MAPTMEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180083203-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-03-22 | — | — | US | disclosed |
| US-20180083203-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180083203-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NES, CACNA2D4, PGLS | TNKS 2444/4885TNKS2 2588/4885MAPT 451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.